Drugs & TargetsFree Lenvima Receives Breakthrough Therapy Designation from FDA July 30, 2015Vol.41 No.30
Drugs & Targets Cleave Biosciences’s CB-5083 receives FDA orphan drug designation July 17, 2015Vol.41 No.28
